Although lacking studies in CML, it was proven that BIBR1532 is effective in suppressing disease progression in Burkitt’s lymphoma (BL) via direct TERT suppression. This evidence concerns the gene TERT and chronic myelogenous leukemia, BCR-ABL1 positive.